Treatment of septic shock with continuous HDF using 2 PMMA hemofilters for enhanced intensity

International Journal of Artificial Organs

Volumn 35, Issue 1, 2012, Pages 3-14

  Matsumura, Yosuke ^a   Oda, Shigeto ^a   Sadahiro, Tomohito ^a   Nakamura, Masataka ^a   Hirayama, Yo ^a   Watanabe, Eizo ^a   Abe, Ryuzo ^a   Nakada, Taka aki ^a   Tateishi, Yoshihisa ^a   Oshima, Taku ^a   Shinozaki, Koichiro ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Continuous hemodiafiltration; Cytokine adsorption; Cytokines; Hemofilter; Polymethylmethacrylate membrane; Septic shock

Indexed keywords

BLOOD; BLOOD PRESSURE; INTENSIVE CARE UNITS; MEMBRANES; POLYESTERS;

CONTINUOUS HEMODIAFILTRATION; CYTOKINE ADSORPTION; CYTOKINES; HEMODIAFILTRATION; HEMOFILTERS; MEMBRANE AREA; POLYMETHYLMETHACRYLATE MEMBRANE; SEPTIC SHOCKS; SURVIVAL RATE;

REFRACTORY MATERIALS;

CYTOKINE; INTERLEUKIN 6; LACTIC ACID; POLY(METHYL METHACRYLATE); BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ARTIFICIAL MEMBRANE; CASE CONTROL STUDY; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SURVIVAL RATE; BLOOD; BLOOD PRESSURE; EQUIPMENT DESIGN; HEMODIAFILTRATION; INSTRUMENTATION; INTENSIVE CARE; JAPAN; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SURVIVAL; TIME; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; EQUIPMENT DESIGN; FEMALE; HEMODIAFILTRATION; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; INTERLEUKIN-6; JAPAN; LACTIC ACID; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; POLYMETHYL METHACRYLATE; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862243371     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000044     Document Type: Article

References (30)

1. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420(6917):885-891Medline. doi:10.1038/nature01326
2. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117(2):289-296.Medline. doi:10.1172/JCI30555
3. Kellum JA, Bellomo R, Mehta R, Ronco C. Blood purification in non-renal critical illness. Blood Purif. 2003;21(1):6-13.Medline. doi:10.1159/000067862
4. Venkataraman R, Subramanian S, Kellum JA. Clinical review: extracorporeal blood purification in severe sepsis. Crit Care. 2003;7(2):139-145.Medline. doi:10.1186/cc1889
5. Ronco C, Bonello M, Bordoni V, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 2004;22(1):164-174. Medline. doi:10.1159/000074937
6. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2000;356(9223):26-30.Medline. doi:10.1016/S0140-6736(00)02430-2
7. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. Current topics on cytokine removal technologies. Ther Apher Dial. 2001;5(4):306-314.doi:10.1046/j.1526- 0968.2001.00361.x
8. Cornejo R, Downey P, Castro R, et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med. 2006;32(5):713-722.Medline. doi:10.1007/s00134-006-0118-5
9. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher Dial. 2002;6(3):193-198.doi:10.1046/j.1526-0968.2002.00431.x
10. Hirasawa H, Oda S, Matsuda K. Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol. 2007;156:365-370.Medline. doi:10.1159/000102127
11. Nakada TA, Oda S, Matsuda K, et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14(5-6):257-263.Medline. doi:10.2119/2007-00108.Nakada
12. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644-1655.Medline. doi:10.1378/chest.101.6.1644
13. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858-873. Medline. doi:10.1097/01.CCM.0000117317.18092.E4
14. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.Medline. doi:10.1056/NEJMoa010307
15. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308.Medline. doi:10.1056/NEJM200005043421801
16. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 2005;29(4):169-175.Medline. doi:10.1016/j.cyto.2004.10.010
17. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/ failure in intensive care units: results of a multicenter, prospective study. Working Group on "Sepsis-Related Problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793-1800.Medline. doi:10.1097/00003246-199811000-00016
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.Medline. doi:10.1097/00003246-198510000-00009
19. Kobayashi A, Iwasaki Y, Kimura Y, et al. Early recovery in hemodynamics after direct hemoperfusion with polymyxin B-immobilized fibers may predict mortality rate in patients with septic shock. J Anesth. 2010;24(5):709-715.Medline. doi:10.1007/s00540-010-0986-2
20. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R212.
21. Antonelli M, Levy M, Andrews PJ, et al. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med. 2007;33(4):575-590.Medline. doi:10.1007/s00134-007-0531-4
22. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med. 1997;25(1):58-62.Medline. doi:10.1097/00003246-199701000-00013
23. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001;55:77-104.Medline. doi:10.1146/annurev.micro.55.1.77
24. Alouf JE, Muller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol. 2003;292:429-440.Medline. doi:10.1078/1438-4221-00232
25. Watanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T. Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphisms. Crit Care Med. 2005;33(1):89-97. Medline. doi:10.1097/01.CCM.0000150025.79100.7D
26. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 009;301(23):2445-2452Medline. doi:10.1001/jama.2009.856
27. Ronco C, Kellum JA, Bellomo R, House AA. Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol. 2008;3(2):531-544.Medline. doi:10.2215/CJN.03830907
28. Kobe Y, Oda S, Matsuda K, Nakamura M, Hirasawa H. Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Purif. 2007;25(5-6):446-453.Medline. doi:10.1159/000111568
29. Taniguchi T, Takemoto Y, Tsuda K, Inaba H, Yamamoto K. Effects of post-treatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats. Blood Purif. 2006;24(5-6):460-464.Medline. doi:10.1159/000095554
30. Haase M, Silvester W, Uchino S, et al. A pilot study of highadsorption hemofiltration in human septic shock. Int J Artif Organs. 2007;30(2):108-117.